Veterinary Drugs Market Insights, 2016-2024

Veterinary Drugs Market (Product Type - Anti-infective, Anti-inflammatory, and Parasiticides; Animal - Companion and Livestock; Route of Administration - Oral, Parenteral, and Topical) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Veterinary Drugs Market: Overview

The global veterinary drugs market is estimated to register growth at a CAGR of 5.1% during the forecast period of 2016 to 2024. Thus, the market for veterinary drugs is projected to expand from the valuation of US$17.2 Bn in 2015 to US$26.7 Bn by 2024. This market growth can be ascribed to several factors such as a rise in the trend of pet adoption across several parts of the globe.

The latest study by Transparency Market Research (TMR) provides complete synopsis of factors influencing the growth curve of the global veterinary drugs market. Thus, the report covers assessment on major aspects such as growth drivers, challenges, growth opportunities, trends, and competition landscape in the market.

The analysts at TMR have performed the segmentation of the global veterinary drugs market based on many crucial parameters such as product, animal, route of administration, and region.

Based on product, the market for veterinary drugs is classified into four main categories such as anti-inflammatory, parasiticides, anti-infective, and others. In terms of animal, the market is segmented into two main parts, companion and livestock. On the basis of route of administration, the veterinary drugs market is divided into parenteral, topical, and oral.

veterinary drugs market

Rising Trend of Companion Ownership of Animals to Fuel Demand for Veterinary Drugs

People from across the globe, specifically from several developed nations, are inclining toward the acceptance of concept of companion ownership. This factor is fueling the growth of veterinary drugs market. Furthermore, increasing awareness among owners regarding the health of their pets is driving the demand for veterinary drugs that can help in improving mobility as well as quality of life in companion animals.

The veterinary drugs market is being driven by the increasing support from government bodies of many countries around the world. For instance, Animal Husbandry Department of the Government of India and the Ministry of AYUSH entered into an agreement that focuses on the exploration of possibilities of development of quality drugs intended for animals using medicinal herbs.

Several developing nations including India domesticate livestock animals due to their economic value. These animals are important part of different agricultural and farming activities. This factor is estimated to work in favor of the growth of the veterinary drugs market in the forthcoming years.

North America: Dominating Region; Latin America & Asia pacific Lucrative Regions for Market Enterprises

Some of the important regions supporting the growth of the global veterinary drugs market include Europe, North America, Latin America, Middle East & Africa, and Asia Pacific. Of them, North America dominates the market owing to many factors such as increase in the pet adoption by major regional population. Moreover, the veterinary drugs industry is estimated to gain high demand prospects in Latin America and Asia Pacific owing to surging cases of animal diseases in both the regions.

Leading Manufacturers Increase Investments in R&D Projects to Develop Advanced Products

Together with fragmented nature, the global veterinary drugs market experiences presence of many well-established players. As a result, the competition level in the market seem to be highly intense. To stay ahead in the market competition, companies are using different strategic moves such as mergers, acquisitions, partnerships, and collaborations. Moreover, many enterprises are increasing investments in R&D projects, which are focused on the development and launch of advanced products. In addition, they are focused on improving the efficiency of their existing product offerings.  These factors are creating ample growth opportunities in the market for veterinary drugs.

The COVID-19 pandemic has impacted negatively on the growth of major industries including the veterinary drugs industry. Manufacturers in the veterinary drugs market are strategizing their moves in order to maintain their revenue streams during the pandemic situations.

Some key players operating in the veterinary drugs market include Boehringer Ingelheim GmbH, Dechra Pharmaceuticals PLC., Vetoquinol, Virbac, Ceva Santé Animale, Elanco Animal Health (Eli Lilly and Company), and Bayer AG.

The Global Veterinary Drugs Market has been segmented as follows:

by Product

 

  • Anti-infective
  • Anti-inflammatory
  • Parasiticides
  • Others

by Animal

  • Companion
  • Livestock

by Route of Distribution

  • Oral
  • Parenteral
  • Topical

by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions

What is the total market worth of veterinary drugs market?

The global veterinary drugs market was worth US$17.2 Bn and is projected to reach a value of US$26.7 Bn by the end of 2024

What is the anticipated CAGR of the veterinary drugs market in the forecast period?

Veterinary drugs market is anticipated to grow at a CAGR of 5.1% during the forecast period

Which region is expected to project the highest market share in the global veterinary drugs market?

North America accounted for a major share of the global veterinary drugs market

What are the key driving factors for the growth of the veterinary drugs market?

Veterinary Drugs Market is driven by increase in the pet adoption by major regional population, surging cases of animal diseases and increasing support from government bodies

Who are the key players in the global veterinary drugs market?

Key players in the global veterinary drugs market include Boehringer Ingelheim GmbH, Dechra Pharmaceuticals PLC., Vetoquinol, Virbac, Ceva Santé Animale, Elanco Animal Health (Eli Lilly and Company), and Bayer AG

    Chapter 1. Preface 
    1.1. Report Scope and Market Segmentation 
    1.2. Research Highlights

    Chapter 2. Assumptions and Research Methodology 
    2.1. Assumptions
    2.2. Research Methodology

    Chapter 3. Executive Summary 
    3.1. Global Veterinary Drugs Market : Snapshot, 2015
    3.2. Global Veterinary Drugs Market : Opportunity Map

    Chapter 4. Market Overview
    4.1. Product Overview
    4.2. Global Veterinary Drugs Market Size (US$ Mn) Forecast, 2014–2024 
    4.3. Global Veterinary Drugs Market Outlook
    4.4. Global Veterinary Drugs Market : Key Industry Events
    4.5. Global Veterinary Drugs Market : Porter's Analysis
    4.6. Key Product Opportunities

    Chapter 5. Market Dynamics
    5.1. Drivers and Restraints Snapshot Analysis
    5.2. Drivers
           5.2.1. Increase in pet ownership & spending on companion animals
           5.2.2. Increased medical and surgical capabilities for companion animals
           5.2.3. Greater emphasis on prevention and wellness by veterinarians and owners
           5.2.4. Evolution of new products to combat emergence of new diseases particularly to cope with zoonotic disease concerns 
           5.2.5. Increased meat consumption and  demand for high quality proteins driving demand for livestock animals
    5.3. Restraints
           5.3.1. Lack of novel veterinary drugs in the global market
           5.3.2. Rising concern about the use of antibiotics and growth promoters in food animals
           5.3.3. Prevalence of counterfeit medicines 
    5.4. Global Veterinary Drugs Market : Opportunity Analysis
    5.5. Opportunities
           5.5.1. Biologics and specialty care offer potential opportunities for players 
           5.5.2. Growing awareness and affordability of drugs for pets and livestock offer significant opportunity to new entrants
    5.6. Key Trends
           5.6.1. Launch of generic versions of veterinary drugs by prominent players
           5.6.2. Increase in pet insurance globally
           5.6.3. Targeted in-licensing and strategic acquisitions by leading players
           5.6.4. Viral disease outbreak demands newer medicines every time

    Chapter 6. Veterinary Drugs Market Analysis, by Product Type
    6.1. Key Findings
    6.2. Introduction
    6.3. Global Veterinary Drugs Market Value Share Analysis, by Product Type
    6.4. Veterinary Drugs Market Analysis, by Product Type 
           6.4.1. Anti-infective
           6.4.2. Anti-inflammatory
           6.4.3. Parasiticides
           6.4.4. Others
    6.5. Market Attractiveness Analysis, by Product Type
    6.6. Key Trends

    Chapter 7. Veterinary Drugs Market Analysis, by Animal Type
    7.1. Key Findings
    7.2. Introduction
    7.3. Global Veterinary Drugs Market Value Share Analysis, by Animal Type
    7.4. Veterinary Drugs Market Analysis, by Animal Type
           7.4.1. Companion
           7.4.2. Livestock
    7.5. Market Attractiveness Analysis, by Animal Type
    7.6. Key Trends

    Chapter 8. Veterinary Drugs Market Analysis, by Route of Administration
    8.1. Key Findings
    8.2. Introduction
    8.3. Global Veterinary Drugs Market Value Share Analysis, by Route of Administration
    8.4. Veterinary Drugs Market Analysis, by Route of Administration
           8.4.1. Oral
           8.4.2. Parenteral
           8.4.3. Topical
    8.5. Market Attractiveness Analysis, by Route of Administration
    8.6. Key Trends

    Chapter 9. Veterinary Drugs Market Analysis, by Region
    9.1. Global Veterinary Drugs Market Snapshot, by Country
    9.2. Global Veterinary Drugs Market Value Share Analysis, by Region
    9.3. Veterinary Drugs Market Forecast, by Region
    9.4. Market Attractiveness Analysis, by Region

    Chapter 10. North America Veterinary Drugs Market Analysis
    10.1. Key Findings
    10.2. Market Overview
    10.3. Market Analysis, by Product
           10.3.1. Market Value Share Analysis, by Product
           10.3.2. Market Size (US$ Mn) Forecast, by Product
                     10.3.2.1. Anti-infective
                     10.3.2.2. Anti-inflammatory
                     10.3.2.3. Parasiticides
                     10.3.2.4. Others
    10.4. Market Analysis, by Animal
           10.4.1. Market Value Share Analysis, by Animal
           10.4.2. Market Size (US$ Mn) Forecast, by Animal
                     10.4.2.1. Companion
                     10.4.2.2. Livestock
    10.5. Market Analysis, by Route of Administration
           10.5.1. Market Value Share Analysis, by Route of Administration
           10.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                     10.5.2.1. Oral
                     10.5.2.2. Parenteral
                     10.5.2.3. Topical
    10.6. Market Analysis, by Country
           10.6.1. Market Value Share Analysis, by Country
           10.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                     10.6.2.1. U.S.
                     10.6.2.2. Canada
    10.7. Market Attractiveness Analysis
           10.7.1. by Product 
           10.7.2. by Animal
           10.7.3. by Route of Administration
           10.7.4. by Country
    10.8. Market Trends

    Chapter 11. Europe Veterinary Drugs Market Analysis
    11.1. Key Findings
    11.2. Market Overview
    11.3. Market Analysis, by Product
           11.3.1. Market Value Share Analysis, by Product
           11.3.2. Market Size (US$ Mn) Forecast, by Product
                     11.3.2.1. Anti-infective
                     11.3.2.2. Anti-inflammatory
                     11.3.2.3. Parasiticides
                     11.3.2.4. Others
    11.4. Market Analysis, by Animal
           11.4.1. Market Value Share Analysis, by Animal
           11.4.2. Market Size (US$ Mn) Forecast, by Animal
                     11.4.2.1. Companion
                     11.4.2.2. Livestock
    11.5. Market Analysis, by Route of Administration
           11.5.1. Market Value Share Analysis, by Route of Administration
           11.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                     11.5.2.1. Oral
                     11.5.2.2. Parenteral
                     11.5.2.3. Topical
    11.6. Market Analysis, by Country
           11.6.1. Market Value Share Analysis, by Country
           11.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                     11.6.2.1. U.K.
                     11.6.2.2. Germany
                     11.6.2.3. Italy
                     11.6.2.4. France
                     11.6.2.5. Spain
                     11.6.2.6. Russia
                     11.6.2.7. Rest of Europe
    11.7. Market Attractiveness Analysis
           11.7.1. by Product 
           11.7.2. by Animal
           11.7.3. by Route of Administration
           11.7.4. by Country
    11.8. Market Trends

    Chapter 12. Asia Pacific Veterinary Drugs Market Analysis
    12.1. Key Findings
    12.2. Market Overview
    12.3. Market Analysis, by Product
           12.3.1. Market Value Share Analysis, by Product
           12.3.2. Market Size (US$ Mn) Forecast, by Product
                     12.3.2.1. Anti-infective
                     12.3.2.2. Anti-inflammatory
                     12.3.2.3. Parasiticides
                     12.3.2.4. Others
    12.4. Market Analysis, by Animal
           12.4.1. Market Value Share Analysis, by Animal
           12.4.2. Market Size (US$ Mn) Forecast, by Animal
                     12.4.2.1. Companion
                     12.4.2.2. Livestock
    12.5. Market Analysis, by Route of Administration
           12.5.1. Market Value Share Analysis, by Route of Administration
           12.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                     12.5.2.1. Oral
                     12.5.2.2. Parenteral
                     12.5.2.3. Topical
    12.6. Market Analysis, by Country
           12.6.1. Market Value Share Analysis, by Country
           12.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                     12.6.2.1. China
                     12.6.2.2. Japan
                     12.6.2.3. India
                     12.6.2.4. Australia & New Zealand
                     12.6.2.5. Rest of Asia Pacific
    12.7. Market Attractiveness Analysis
           12.7.1. by Product 
           12.7.2. by Animal
           12.7.3. by Route of Administration
           12.7.4. by Country
    12.8. Market Trends

    Chapter 13. Latin America Veterinary Drugs Market Analysis
    13.1. Key Findings
    13.2. Market Overview
    13.3. Market Analysis, by Product
           13.3.1. Market Value Share Analysis, by Product
           13.3.2. Market Size (US$ Mn) Forecast, by Product
                     13.3.2.1. Anti-infective
                     13.3.2.2. Anti-inflammatory
                     13.3.2.3. Parasiticides
                     13.3.2.4. Others
    13.4. Market Analysis, by Animal       
           13.4.1. Market Value Share Analysis, by Animal
           13.4.2. Market Size (US$ Mn) Forecast, by Animal
                     13.4.2.1. Companion
                     13.4.2.2. Livestock
    13.5. Market Analysis, by Route of Administration
           13.5.1. Market Value Share Analysis, by Route of Administration
           13.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                     13.5.2.1. Oral
                     13.5.2.2. Parenteral
                     13.5.2.3. Topical
    13.6. Market Analysis, by Country
           13.6.1. Market Value Share Analysis, by Country
           13.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                     13.6.2.1. Brazil
                     13.6.2.2. Mexico
                     13.6.2.3. Rest of Latin America
    13.7. Market Attractiveness Analysis
           13.7.1. by Product 
           13.7.2. by Animal
           13.7.3. by Route of Administration
           13.7.4. by Country
    13.8. Market Trends

    Chapter 14. Middle East & Africa Veterinary Drugs Market Analysis
    14.1. Key Findings
    14.2. Market Overview
    14.3. Market Analysis, by Product
           14.3.1. Market Value Share Analysis, by Product
           14.3.2. Market Size (US$ Mn) Forecast, by Product
                     14.3.2.1. Anti-infective
                     14.3.2.2. Anti-inflammatory
                     14.3.2.3. Parasiticides
                     14.3.2.4. Others
    14.4. Market Analysis, by Animal
           14.4.1. Market Value Share Analysis, by Animal
           14.4.2. Market Size (US$ Mn) Forecast, by Animal
                     14.4.2.1. Companion
                     14.4.2.2. Livestock
    14.5. Market Analysis, by Route of Administration
           14.5.1. Market Value Share Analysis, by Route of Administration
           14.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                     14.5.2.1. Oral
                     14.5.2.2. Parenteral
                     14.5.2.3. Topical
    14.6. Market Analysis, by Country
           14.6.1. Market Value Share Analysis, by Country
           14.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                     14.6.2.1. GCC Countries
                     14.6.2.2. South Africa
                     14.6.2.3. Rest of Middle East & Africa
    14.7. Market Attractiveness Analysis
           14.7.1. by Product 
           14.7.2. by Animal
           14.7.3. by Route of Administration
           14.7.4. by Country
    14.8. Market Trends

    Chapter 15. Company Profiles
    15.1. Veterinary Drugs Market Share Analysis, by Company, 2016 (Estimated)
    15.2. Competition Matrix
    15.3. Company Profiles
           15.3.1. Bayer AG
                     15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.3.1.2. Financial Overview
                     15.3.1.3. Product Portfolio
                     15.3.1.4. SWOT Analysis
                     15.3.1.5. Strategic Overview
           15.3.2. Boehringer Ingelheim GmbH
                     15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.3.2.2. Financial Overview
                     15.3.2.3. Product Portfolio
                     15.3.2.4. SWOT Analysis
                     15.3.2.5. Strategic Overview
           15.3.3. Ceva Santé Animale 
                     15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.3.3.2. Financial Overview
                     15.3.3.3. Product Portfolio
                     15.3.3.4. SWOT Analysis
                     15.3.3.5. Strategic Overview
           15.3.4. Dechra Pharmaceuticals PLC
                     15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.3.4.2. Financial Overview
                     15.3.4.3. Product Portfolio
                     15.3.4.4. SWOT Analysis
                     15.3.4.5. Strategic Overview
           15.3.5. Eli Lilly and Company (Elanco Animal Health)
                     15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.3.5.2. Financial Overview
                     15.3.5.3. Product Portfolio
                     15.3.5.4. SWOT Analysis
                     15.3.5.5. Strategic Overview
           15.3.6. Merck Animal Health 
                     15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.3.6.2. Financial Overview
                     15.3.6.3. Product Portfolio
                     15.3.6.4. SWOT Analysis
                     15.3.6.5. Strategic Overview
           15.3.7. Virbac
                     15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.3.7.2. Financial Overview
                     15.3.7.3. Product Portfolio
                     15.3.7.4. SWOT Analysis
                     15.3.7.5. Strategic Overview
           15.3.8. Vetoquinol S.A.
                     15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.3.8.2. Financial Overview
                     15.3.8.3. Product Portfolio
                     15.3.8.4. SWOT Analysis
                     15.3.8.5. Strategic Overview
           15.3.9. Zoetis, Inc. 
                     15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.3.9.2. Financial Overview
                     15.3.9.3. Product Portfolio
                     15.3.9.4. SWOT Analysis
                     15.3.9.5. Strategic Overview

    List of Tables

    Table 1: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
    Table 2: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type Type, 2014–2024
    Table 3: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
    Table 4: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Region, 2014–2024
    Table 5: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 2014–2024
    Table 6: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
    Table 7: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
    Table 8: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 2014–2024
    Table 9: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 2014–2024
    Table 10: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
    Table 11: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
    Table 12: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 2014–2024
    Table 13: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 2014–2024
    Table 14: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
    Table 15: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
    Table 16: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 2014–2024
    Table 17: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 2014–2024
    Table 18: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
    Table 19: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
    Table 20: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 2014–2024
    Table 21: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 2014–2024
    Table 22: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
    Table 23: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
    Table 24: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 2014–2024

    List of Figures

    Figure 1: Global Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
    Figure 2: Global Veterinary Drugs Market Value Share, by Product Type, 2016 and 2024
    Figure 3: Global Anti-infective Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
    Figure 4: Global Anti-inflammatory Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
    Figure 5: Global Parasiticides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
    Figure 6: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
    Figure 7: Global Veterinary Drugs Market Attractiveness Analysis, by Product Type, 2016–2024
    Figure 8: Global Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
    Figure 9: Global Companion Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
    Figure 10: Global Livestock Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
    Figure 11: Global Veterinary Drugs Market Attractiveness Analysis, by Animal Type, 2016–2024
    Figure 12: Global Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
    Figure 13: Global Oral Route of Administration Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
    Figure 14: Global Parenteral Route of Administration Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
    Figure 15: Global Topical Route of Administration Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
    Figure 16: Global Veterinary Drugs Market Attractiveness Analysis, by Route of Administration, 2016–2024
    Figure 17: Global Veterinary Drugs Market Value Share, by Region, 2016 and 2024
    Figure 18: Global Veterinary Drugs Market Attractiveness Analysis, by Region, 2016–2024
    Figure 19: North America Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
    Figure 20: North America Veterinary Drugs Market Attractiveness Analysis, by Country
    Figure 21: North America Veterinary Drugs Market Value Share, by Product, 2016 and 2024
    Figure 22: North America Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
    Figure 23: North America Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
    Figure 24: North America Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
    Figure 25: North America Veterinary Drugs Market Attractiveness Analysis, by Product
    Figure 26: North America Veterinary Drugs Market Attractiveness Analysis, by Animal Type
    Figure 27: North America Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
    Figure 28: Europe Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
    Figure 29: Europe Veterinary Drugs Market Attractiveness Analysis, by Country
    Figure 30: Europe Veterinary Drugs Market Value Share, by Product, 2016 and 2024
    Figure 31: Europe Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
    Figure 32: Europe Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
    Figure 33: Europe Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
    Figure 34: Europe Veterinary Drugs Market Attractiveness Analysis, by Product
    Figure 35: Europe Veterinary Drugs Market Attractiveness Analysis, by Animal Type
    Figure 36: Europe Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
    Figure 37: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
    Figure 38: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Country
    Figure 39: Asia Pacific Veterinary Drugs Market Value Share, by Product, 2016 and 2024
    Figure 40: Asia Pacific Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
    Figure 41: Asia Pacific Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
    Figure 42: Asia Pacific Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
    Figure 43: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Product
    Figure 44: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Animal Type
    Figure 45: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
    Figure 46: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
    Figure 47: Latin America Veterinary Drugs Market Attractiveness Analysis, by Country
    Figure 48: Latin America Veterinary Drugs Market Value Share, by Product, 2016 and 2024
    Figure 49: Latin America Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
    Figure 50: Latin America Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
    Figure 51: Latin America Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
    Figure 52: Latin America Veterinary Drugs Market Attractiveness Analysis, by Product
    Figure 53: Latin America Veterinary Drugs Market Attractiveness Analysis, by Animal Type
    Figure 54: Latin America Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
    Figure 55: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
    Figure 56: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Country
    Figure 57: Middle East & Africa Veterinary Drugs Market Value Share, by Product, 2016 and 2024
    Figure 58: Middle East & Africa Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
    Figure 59: Middle East & Africa Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
    Figure 60: Middle East & Africa Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
    Figure 61: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Product
    Figure 62: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Animal Type
    Figure 63: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
    Figure 64: Global Veterinary Drugs Market Share Analysis, by Company, 2016 (Estimated)

     

Copyright © Transparency Market Research, Inc. All Rights reserved